New insights into insulin resistance pathophysiology: how it affects glucose and lipid metabolism (Q34325597)

1 August 2017

1 reference

title

New insights into insulin resistance pathophysiology: how it affects glucose and lipid metabolism (English)

1 reference

1 August 2017

1 reference

1 reference

V Col

1

1 reference

1 August 2017

language of work or name

1 reference

1 May 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

56

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

155-162

1 reference

Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1179/ACB.2001.025

Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2001.025

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2001.025

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2001.025

Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2001.025

Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2001.025

Disruption of IRS-2 causes type 2 diabetes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2001.025

Altered function of insulin receptor substrate-1-deficient mouse islets and cultured beta-cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2001.025

Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2001.025

Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediat

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2001.025

Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2001.025

TNF-alpha and insulin resistance: summary and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2001.025

Divergent Signaling Capacities of the Long and Short Isoforms of the Leptin Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2001.025

Leptin receptor action in hepatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2001.025

Is fasting leptin associated with insulin resistance among nondiabetic individuals? The Miami Community Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2001.025

Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study. The Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2001.025

Modulation of insulin activities by leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2001.025

Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2001.025

Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2001.025

Facilitative glucose transporters: regulatory mechanisms and dysregulation in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2001.025

The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2001.025

Regulation of apo A-I gene expression by fibrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2001.025

Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2001.025

Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2001.025

Obesity associated with a mutation in a genetic regulator of adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2001.025

Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2001.025

Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2001.025

Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2001.025

Cellular mechanisms of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2001.025

Peroxisome proliferator-activated receptors and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2001.025

Transcriptional control of triglyceride metabolism: fibrates and fatty acids change the expression of the LPL and apo C-III genes by activating the nuclear receptor PPAR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2001.025

The effects of fibrates and thiazolidinediones on plasma triglyceride metabolism are mediated by distinct peroxisome proliferator activated receptors (PPARs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2001.025

Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2001.025

Exercise modulates postreceptor insulin signaling and glucose transport in muscle-specific insulin receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2001.025

The mechanisms of insulin sensitivity improving effects of angiotensin converting enzyme inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2001.025

Imidapril, an angiotensin-converting enzyme inhibitor, improves insulin sensitivity by enhancing signal transduction via insulin receptor substrate proteins and improving vascular resistance in the Zucker fatty rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2001.025

Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension

21 January 2018

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.1038/47254

15 July 2023

Identifiers

DOI

10.1179/ACB.2001.025

1 reference

1 August 2017

1 reference